Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6196)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rou WS, Lee BS, Moon HS, Lee ES, Kim SH, Lee HY. Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization. World J Gastroenterol 2014; 20(22): 6995-7004 [PMID: 24944494 DOI: 10.3748/wjg.v20.i22.6995] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6995.htm |
| Number | Citing Articles |
| 1 |
Crisanta H. Ilagan, Debra A. Goldman, Mithat Gönen, Victoria G. Aveson, Michelle Babicky, Vinod P. Balachandran, Jeffrey A. Drebin, William R. Jarnagin, Alice C. Wei, T. Peter Kingham, Ghassan K. Abou-Alfa, Karen T. Brown, Michael I. D’Angelica. Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses. Annals of Surgical Oncology 2022; 29(11): 6815 doi: 10.1245/s10434-022-12036-8
|
| 2 |
Timo A. Auer, Lukas Müller, Daniel Schulze, Melina Anhamm, Dominik Bettinger, Verena Steinle, Johannes Haubold, David Zopfs, Daniel Pinto dos Santos, Michel Eisenblätter, Bernhard Gebauer, Roman Kloeckner, Federico Collettini. CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma. Radiology 2024; 310(2) doi: 10.1148/radiol.232044
|
| 3 |
Xavier Adhoute, Guillaume Penaranda, Paul Castellani, Herve Perrier, Marc Bourliere. Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?. World Journal of Hepatology 2015; 7(3): 521-531 doi: 10.4254/wjh.v7.i3.521
|
| 4 |
Jiani Zhao, Lianli Zeng, Qian Wu, Li Wang, Jun Lei, Hongliang Luo, Fengming Yi, Yiping Wei, Jiao Yu, Wenxiong Zhang. Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review. Chemotherapy 2019; 64(5-6): 248 doi: 10.1159/000505739
|
| 5 |
Sohyun Park, Tae-Sung Kim, Se Hun Kang, Hyun Beom Kim, Joong-Won Park, Seok-ki Kim. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization. Medicine 2018; 97(37): e12311 doi: 10.1097/MD.0000000000012311
|
| 6 |
Xin-Fei Xu, Hao Xing, Jun Han, Zhen-Li Li, Wan-Yee Lau, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yong-Yi Zeng, Chao Li, Meng-Chao Wu, Feng Shen, Tian Yang. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma. JAMA Surgery 2019; 154(3): 209 doi: 10.1001/jamasurg.2018.4334
|
| 7 |
Dong Ik Cha, Min Woo Lee, Soo Hyun Ahn, Kyoung Doo Song, Tae Wook Kang, Dong Hyun Sinn, Hyunchul Rhim. Rescue therapy for local tumor progression after radiofrequency ablation of small hepatocellular carcinoma: a comparison between repeated ablation and transcatheter arterial chemoembolization. The British Journal of Radiology 2023; 96(1146) doi: 10.1259/bjr.20211037
|
| 8 |
Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Shogo Iwabuchi, Kotaro Matsunaga, Hirotoshi Ebinuma, Kento Imajo, Yousuke Aoki, Hidetsugu Saito, Etsuo Kunieda. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer 2016; 122(13): 2041 doi: 10.1002/cncr.30008
|
| 9 |
Chih-Yang Hsiao, Cheng-Maw Ho, Ming-Chih Ho, Hou-Ying Cheng, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Risk factors, patterns, and outcome predictors of late recurrence in patients with hepatocellular carcinoma after curative resection: A large cohort study with long-term follow-up results. Surgery 2024; 176(1): 2 doi: 10.1016/j.surg.2024.02.006
|
| 10 |
Sumin Lee, Hojin Kim, Yunseo Ji, Byungchul Cho, Su Ssan Kim, Jinhong Jung, Jungwon Kwak, Jin-hong Park, Sang-wook Lee, Jong Hoon Kim, Sang Min Yoon. Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34676-1
|
| 11 |
Cheng-Shi Chen, Fang-Kun Li, Chen-Yang Guo, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Lin Zheng, Deng-Wei Zong, Jun-Li Ma, Li Jiang, Hai-Liang Li. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget 2016; 7(6): 7241 doi: 10.18632/oncotarget.6892
|
| 12 |
Dan G. Duda, Franziska D. Hauth. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 153 doi: 10.1007/978-981-19-0063-1_18
|
| 13 |
Shin Ok Jeong, Eui Bae Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Dong Erk Goo, Su Yeon Park. Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma. Gut and Liver 2017; 11(3): 409 doi: 10.5009/gnl16001
|
| 14 |
Jun Qian, Elsie Oppermann, Andreas Tran, Ulli Imlau, Kun Qian, Thomas Josef Vogl. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World Journal of Gastroenterology 2016; 22(21): 5042-5049 doi: 10.3748/wjg.v22.i21.5042
|
| 15 |
Kun Qian, Feng Zhang, Stephen K. Allison, Chuansheng Zheng, Xiaoming Yang. Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status. Journal of Interventional Medicine 2021; 4(1): 1 doi: 10.1016/j.jimed.2020.10.008
|
| 16 |
Kun He, Xinyu Liu, Zelong Yang. Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 139 doi: 10.2147/JHC.S399299
|
| 17 |
Jieun Byun, So Yeon Kim, Jin Hyoung Kim, Min Ju Kim, Changhoon Yoo, Ju Hyun Shim, Seung Soo Lee. Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging. Acta Radiologica 2021; 62(12): 1548 doi: 10.1177/0284185120971844
|
| 18 |
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Ryuichi Noguchi, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Takuya Kubo, Hitoshi Yoshiji. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization. Oncology Letters 2017; 14(3): 3028 doi: 10.3892/ol.2017.6489
|
| 19 |
Tim A. Labeur, R. Bart Takkenberg, Heinz-Josef Klümpen, Otto M. van Delden. Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2019; 42(2): 230 doi: 10.1007/s00270-018-2118-6
|
| 20 |
Yong Li, Feifan Zhou, Fang Liu, Meng Wang, Wenge Xing. Experimental Study on Evaluation of Blood Supply Level and Embolization Ratio of Liver Cancer Based on I-Flow Software. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820970665
|
| 21 |
Mariko M. Nakano, Akira Yamamoto, Norifumi Nishida, Masao Hamuro, Shinichi Hamamoto, Atsushi Jogo, Etsuji Sohgawa, Ken Kageyama, Tetsuya Minami, Yukio Miki. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE). Japanese Journal of Radiology 2019; 37(7): 543 doi: 10.1007/s11604-019-00840-4
|
| 22 |
Jeong Yeop Lee, Byung Chan Lee, Hyoung Ook Kim, Suk Hee Heo, Sang Soo Shin, Yong Yeon Jeong. Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01839-6
|
| 23 |
Hua Yang, Jie Wang, Zehuan Li, Yi Yang, Liuxiao Yang, Yong Zhang, Yinghong Shi, Ya Cao, Jian Zhou, Zheng Wang, Qing Chen. Risk Factors and Outcomes of Early Relapse After Curative Resection of Intrahepatic Cholangiocarcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00854
|
| 24 |
Goro Kasuya, Hirotoshi Kato, Shigeo Yasuda, Hiroshi Tsuji, Shigeru Yamada, Yasuo Haruyama, Gen Kobashi, Daniel K. Ebner, Naomi Nagatake Okada, Hirokazu Makishima, Masaru Miyazaki, Tadashi Kamada, Hirohiko Tsujii. Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials. Cancer 2017; 123(20): 3955 doi: 10.1002/cncr.30816
|
| 25 |
Ling-Ling Weng, Jian-Feng Xiang, Jin-Bo Lin, Shang-Hui Yi, Li-Tao Yang, Yi-Sheng Li, Hao-Tao Zeng, Sheng-Ming Lin, Dong-Wei Xin, Hai-Liang Zhao, Shu-Qi Qiu, Tao Chen, Min-Guang Zhang. Asparagus Polysaccharide and Gum with Hepatic Artery Embolization Induces Tumor Growth and Inhibits Angiogenesis in an Orthotopic Hepatocellular Carcinoma Model. Asian Pacific Journal of Cancer Prevention 2015; 15(24): 10949 doi: 10.7314/APJCP.2014.15.24.10949
|
| 26 |
Yusuke Matsui, Masahiro Horikawa, Younes Jahangiri Noudeh, John A. Kaufman, Kenneth J. Kolbeck, Khashayar Farsad. Baseline tumor Lipiodol uptake after transarterial chemoembolization for hepatocellular carcinoma: identification of a threshold value predicting tumor recurrence. Radiology and Oncology 2017; 51(4): 393 doi: 10.1515/raon-2017-0030
|
| 27 |
Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park. Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization. The Korean Journal of Internal Medicine 2019; 34(6): 1223 doi: 10.3904/kjim.2018.058
|
| 28 |
Izumi Miki, Satoru Murata, Fumio Uchiyama, Daisuke Yasui, Tatsuo Ueda, Fumie Sugihara, Hidemasa Saito, Hidenori Yamaguchi, Ryusuke Murakami, Chiaki Kawamoto, Eiji Uchida, Shin-ichiro Kumita. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy. World Journal of Gastroenterology 2017; 23(35): 6437-6447 doi: 10.3748/wjg.v23.i35.6437
|
| 29 |
Shamar Young, Tina Sanghvi, Sandeep Sharma, Cameron Richardson, Nathan Rubin, Masters Richards, Donna D'Souza, Siobhan Flanagan, Jafar Golzarian. Local recurrence following complete radiologic response in patients treated with transarterial chemoembolization for hepatocellular carcinoma. Diagnostic and Interventional Imaging 2022; 103(3): 143 doi: 10.1016/j.diii.2022.01.006
|
| 30 |
Jian-Xiang Niu, Xing-Kai Meng, Jian-Jun Ren. Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques. World Journal of Gastroenterology 2015; 21(44): 12605-12611 doi: 10.3748/wjg.v21.i44.12605
|